EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | HCl.C19H30F3NO3 |
| Net Charge | 0 |
| Average Mass | 413.908 |
| Monoisotopic Mass | 413.19446 |
| SMILES | CCCCCCCOc1ccc(CCC(N)(CO)CO)cc1C(F)(F)F.Cl |
| InChI | InChI=1S/C19H30F3NO3.ClH/c1-2-3-4-5-6-11-26-17-8-7-15(12-16(17)19(20,21)22)9-10-18(23,13-24)14-25;/h7-8,12,24-25H,2-6,9-11,13-14,23H2,1H3;1H |
| InChIKey | GEDVJGOVRLHFQG-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Biological Role: | immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. |
| Applications: | anti-inflammatory agent Any compound that has anti-inflammatory effects. antipsoriatic A drug used to treat psoriasis. immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| amiselimod hydrochloride (CHEBI:755832) has role anti-inflammatory agent (CHEBI:67079) |
| amiselimod hydrochloride (CHEBI:755832) has role antipsoriatic (CHEBI:50748) |
| amiselimod hydrochloride (CHEBI:755832) has role immunosuppressive agent (CHEBI:35705) |
| amiselimod hydrochloride (CHEBI:755832) is a (trifluoromethyl)benzenes (CHEBI:83565) |
| Synonyms | Source |
|---|---|
| Amiselimod hydrochloride | ChEMBL |
| MT-1303 | ChEMBL |